We are pioneering a better drug discovery process using systems biology to improve the lives of people with neurodegenerative disorders. YC S15.
Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
United States of America based
- Phenotypic drug discovery (PDD)
- small molecules